Financials
- Fiscal year
- 2025
- Total assets
- €948
- Loss
- -€1,336
- Solvency
- -130.3%
Green Pharma
ActiveSummary
Green Pharma is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The 2025 annual accounts show negative equity (-€1,236) and a net result of -€1,336. Its solvency ranks better than 8% of 22,078 sector peers (NACE 47, fiscal year 2025). The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals.
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€948total assets 2025
- Equity
- -€1,236
- Loss
- -€1,336
Turnover not published (abridged schema)
Structure
- Board
- 1 member
Accounts filed 30 days late
Why 0- Negative equity- Young companyFiled after the deadlineShow the evidence
Checked score
Score 2025
0
/ 100
Critical
Without a bankruptcy probability: score from the figures alone
Financial strength
Weak
Solvency
0
equity -130.3% of total assets
Liquidity
0
short-term debt 230.3%
Profitability
0
return on assets -140.9%
Bankruptcy probability, 12 months
This company is younger than 12 months. There is no public track record yet to base a reliable estimate on, so we'd rather not show a number.
No credit on open account
balance sheet total too small for a liquidity verdict, and equity is negative.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Three signals.
+raises risk○neutral
raises risk · Young company
Founded in 2025, under 3 years in business. Failure risk is statistically highest between 2 and 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-08-2026, 30 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filingDeviation from the deadline
2025
30 days late
← before the deadline
after the deadline →
Checked, nothing found (1)
- Annual accounts filedfiscal year 2025 · micro…
- IncorporationAppointment: MHALLA Abdelkader (non-statutory director)…
Key points
By topic
Board & ownership
- Board
- 1 member
Go to Board & ownership
Timeline
- Events
- 2
- Since
- 2025
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 17-11-2025
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 29
- Who signs
- Each director alone
- Annual meeting
- First Monday of May
- Purpose
- L’activité de pharmacien itinérant et la prestation de services pour les officines…
- Statutory auditor
- No statutory auditor
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.